2022
DOI: 10.1016/j.htct.2021.01.009
|View full text |Cite
|
Sign up to set email alerts
|

Lipoprotein apheresis efficacy and challenges: single center experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 27 publications
0
1
0
Order By: Relevance
“…-with or without major adverse cardiac events (MACE), -with the score of Dutch Lipid Clinic Network criteria ≥ 8, who do not achieve lowering LDL-C by more than 40% with the maximum tolerated dose of statin [4,7].…”
Section: Our Center Treats Patientsmentioning
confidence: 99%
“…-with or without major adverse cardiac events (MACE), -with the score of Dutch Lipid Clinic Network criteria ≥ 8, who do not achieve lowering LDL-C by more than 40% with the maximum tolerated dose of statin [4,7].…”
Section: Our Center Treats Patientsmentioning
confidence: 99%